• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎性乳腺癌的治疗方法

Approach to inflammatory breast cancer.

作者信息

Molckovsky Andrea, Fitzgerald Barbara, Freedman Orit, Heisey Ruth, Clemons Mark

机构信息

Division of Hematology and Medical Oncology at Princess Margaret Hospital in Toronto, Ont.

出版信息

Can Fam Physician. 2009 Jan;55(1):25-31.

PMID:19155362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2628841/
Abstract

OBJECTIVE

To review the definition, clinical presentation, and management of inflammatory breast cancer in primary care.

SOURCES OF INFORMATION

Relevant research and review articles, as well as personal experience of the authors practising in a specialized locally advanced breast cancer program at a comprehensive cancer centre. Evidence is levels II and III.

MAIN MESSAGE

Inflammatory breast cancer is a rare disease that typically presents with a rapidly enlarging erythematous breast, often with no discernable breast mass. Identification of warning signs and recognition of clinical symptoms are crucial to prompt diagnosis and appropriate referral. Management in the primary care setting includes treatment of symptoms, psychosocial support, regular surveillance and follow-up, as well as palliative care.

CONCLUSION

Family physicians are usually the entry point to the health care system and are well positioned to assess inflammation of the breast and recognize the warning signs of an underlying inflammatory breast cancer. They are also important members of the team that provides support for breast cancer patients and their families during treatment, follow-up, and end-of-life care.

摘要

目的

回顾基层医疗中炎性乳腺癌的定义、临床表现及管理。

信息来源

相关研究和综述文章,以及作者在综合癌症中心专门的局部晚期乳腺癌项目中执业的个人经验。证据等级为II级和III级。

主要信息

炎性乳腺癌是一种罕见疾病,通常表现为乳房迅速增大、发红,常无明显乳房肿块。识别警示信号和认识临床症状对于及时诊断和恰当转诊至关重要。基层医疗环境中的管理包括症状治疗、心理社会支持、定期监测和随访以及姑息治疗。

结论

家庭医生通常是医疗保健系统的切入点,具备良好条件来评估乳房炎症并识别潜在炎性乳腺癌的警示信号。他们也是在治疗、随访及临终关怀期间为乳腺癌患者及其家属提供支持的团队的重要成员。

相似文献

1
Approach to inflammatory breast cancer.炎性乳腺癌的治疗方法
Can Fam Physician. 2009 Jan;55(1):25-31.
2
Locally advanced and inflammatory breast cancer.局部晚期炎性乳腺癌
Aust Fam Physician. 2005 Dec;34(12):1027-32.
3
Inflammatory breast cancer in primary care.
Nurse Pract. 2003 May;28(5):58-9. doi: 10.1097/00006205-200305000-00022.
4
Clinical aspects of inflammatory breast cancer.炎性乳腺癌的临床方面
Breast Dis. 2005;22:35-44. doi: 10.3233/bd-2006-22105.
5
Inflammatory breast carcinoma.
Surg Oncol. 1995;4(5):245-54. doi: 10.1016/s0960-7404(10)80003-9.
6
Lactational mastitis and breast abscess - diagnosis and management in general practice.哺乳期乳腺炎和乳腺脓肿——全科医疗中的诊断与管理
Aust Fam Physician. 2011 Dec;40(12):976-9.
7
Differentiating inflammatory breast cancer from acute mastitis.鉴别炎性乳腺癌与急性乳腺炎。
Am Fam Physician. 1995 Sep 1;52(3):929-34.
8
Epidemiology of inflammatory breast cancer (IBC).炎性乳腺癌(IBC)的流行病学
Breast Dis. 2005;22:9-23. doi: 10.3233/bd-2006-22103.
9
Family history of breast cancer. Impact on the disease experience.乳腺癌家族史。对疾病体验的影响。
Cancer Pract. 2000 May-Jun;8(3):135-42. doi: 10.1046/j.1523-5394.2000.83007.x.
10
The British Association of Surgical Oncology Guidelines for surgeons in the management of symptomatic breast disease in the UK (1998 revision). BASO Breast Specialty Group.
Eur J Surg Oncol. 1998 Dec;24(6):464-76. doi: 10.1016/s0748-7983(98)93104-3.

引用本文的文献

1
Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overview.双特异性抗体革新乳腺癌治疗:全面综述。
Front Immunol. 2023 Dec 4;14:1266450. doi: 10.3389/fimmu.2023.1266450. eCollection 2023.
2
Inflammatory breast cancer appearance at presentation is associated with overall survival.炎性乳腺癌的临床表现与总生存期相关。
Cancer Med. 2021 Sep;10(18):6261-6272. doi: 10.1002/cam4.4170. Epub 2021 Jul 30.
3
Pathologic Complete Response (pCR) and Survival of Women with Inflammatory Breast Cancer (IBC): An Analysis Based on Biologic Subtypes and Demographic Characteristics.炎性乳腺癌(IBC)患者的病理完全缓解(pCR)和生存:基于生物学亚型和人口统计学特征的分析。
Int J Environ Res Public Health. 2019 Jan 4;16(1):124. doi: 10.3390/ijerph16010124.
4
Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.用于评估肿瘤特异性治疗的临床相关炎性乳腺癌患者来源异种移植物衍生的离体模型。
PLoS One. 2018 May 16;13(5):e0195932. doi: 10.1371/journal.pone.0195932. eCollection 2018.
5
Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients.对从炎性乳腺癌患者血液中分离出的单个循环肿瘤细胞的突变研究。
Breast Cancer Res Treat. 2017 Jun;163(2):219-230. doi: 10.1007/s10549-017-4176-x. Epub 2017 Mar 7.
6
The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.粘着斑激酶抑制剂CEP-37440在体外和体内对炎性乳腺癌细胞的作用。
Breast Cancer Res. 2016 Mar 24;18(1):37. doi: 10.1186/s13058-016-0694-4.
7
Breast cancer local recurrence under the form of inflammatory carcinoma, treated with concurrent radiation and chemotherapy, a case report.以炎性癌形式出现的乳腺癌局部复发,采用同步放疗和化疗治疗,病例报告。
Rep Pract Oncol Radiother. 2013 Oct 20;19(1):65-8. doi: 10.1016/j.rpor.2013.09.004. eCollection 2014 Jan.
8
AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models.AZD8931是一种对表皮生长因子受体(EGFR)、HER2和HER3信号传导具有同等效力的可逆抑制剂:在HER2未扩增的炎性乳腺癌模型中的临床前活性。
J Exp Clin Cancer Res. 2014 May 30;33(1):47. doi: 10.1186/1756-9966-33-47.
9
Inflammatory breast cancer (IBC): clues for targeted therapies.炎性乳腺癌(IBC):靶向治疗的线索。
Breast Cancer Res Treat. 2013 Jul;140(1):23-33. doi: 10.1007/s10549-013-2600-4. Epub 2013 Jun 21.
10
Idiopathic granulomatous mastitis: a great imitator?特发性肉芽肿性乳腺炎:一个强大的模仿者?
BMJ Case Rep. 2010 Nov 18;2010:bcr0320102844. doi: 10.1136/bcr.03.2010.2844.

本文引用的文献

1
Inflammatory breast cancer: patient advocate view.
Semin Oncol. 2008 Feb;35(1):87-91. doi: 10.1053/j.seminoncol.2007.11.011.
2
Evolving role of imaging modalities in inflammatory breast cancer.影像模态在炎性乳腺癌中的不断演变的作用。
Semin Oncol. 2008 Feb;35(1):51-63. doi: 10.1053/j.seminoncol.2007.11.016.
3
Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis.炎性乳腺癌的病理学方面:第1部分。组织形态学与鉴别诊断。
Semin Oncol. 2008 Feb;35(1):25-32. doi: 10.1053/j.seminoncol.2007.11.013.
4
The epidemiology of inflammatory breast cancer.炎性乳腺癌的流行病学
Semin Oncol. 2008 Feb;35(1):11-6. doi: 10.1053/j.seminoncol.2007.11.018.
5
Defining the clinical diagnosis of inflammatory breast cancer.定义炎性乳腺癌的临床诊断。
Semin Oncol. 2008 Feb;35(1):7-10. doi: 10.1053/j.seminoncol.2007.11.010.
6
Locally advanced and inflammatory breast cancer.局部晚期和炎性乳腺癌。
J Clin Oncol. 2008 Feb 10;26(5):786-90. doi: 10.1200/JCO.2008.15.0243.
7
Trends for inflammatory breast cancer: is survival improving?炎性乳腺癌的趋势:生存率是否正在提高?
Oncologist. 2007 Aug;12(8):904-12. doi: 10.1634/theoncologist.12-8-904.
8
The psychosocial impact of parental cancer on children and adolescents: a systematic review.父母患癌对儿童和青少年的心理社会影响:一项系统综述。
Psychooncology. 2007 Feb;16(2):101-26. doi: 10.1002/pon.1113.
9
"Inflammatory" breast cancer.炎性乳腺癌
Surg Oncol. 2005 Nov;14(3):133-43. doi: 10.1016/j.suronc.2005.07.004. Epub 2005 Sep 9.
10
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.炎性乳腺癌发病率及生存率趋势:美国国立癌症研究所的监测、流行病学与最终结果计划
J Natl Cancer Inst. 2005 Jul 6;97(13):966-75. doi: 10.1093/jnci/dji172.